Is There a Real GLP-1 Coupon? Savings Cards, Free Programs & Samples in 2026

How do you get a GLP-1 savings card?

Each maker runs its own free card. Novo Nordisk makes Wegovy and Ozempic. Eli Lilly makes Zepbound, Mounjaro and Foundayo. The steps are the same for all five.

• Check you qualify: you need commercial insurance, such as a plan from your job or the marketplace. Medicare, Medicaid, TRICARE and VA can't use these cards. Novo's cards also leave out plans with a copay accumulator or maximizer, which don't count the maker's help toward your deductible.
• Sign up on the maker's site: answer a few questions, and you get a card number in minutes.
• Give it to your pharmacy: the pharmacist bills your plan first, then the card. Your share can drop to $25.
• Use it at every refill: the card stays on file when your dose goes up.

A card only works for the brand on your prescription. A Wegovy card won't pay for Ozempic, and a Zepbound card won't pay for Mounjaro.

Does the card work on your dose and at your pharmacy?

Yes. Each card covers every dose of its brand, at most US retail pharmacies and the maker's own pharmacy. The $25 is a floor, not a promise.

• Wegovy card: pen or pill, every dose. Novo pays up to $100 of your share per month of medicine.
• Ozempic card: pen or pill. Novo pays up to $100 a month. Your prescription must be for type 2 diabetes.
• Zepbound card: single-dose pen, every dose. One $25 fill can cover up to three months. Lilly pays up to $100 a month and $1,300 a year.
• Mounjaro card: one $25 fill can cover up to three months. Lilly pays up to $150 a month and $1,950 a year. Your prescription must be for type 2 diabetes.
• Foundayo card: Lilly's daily GLP-1 pill. Lilly pays up to $100 a month and $1,000 a year.

Lilly's three cards end on December 31, 2026. Novo says it will update its prices after that date. Brand pages give the details: Wegovy savings, Ozempic savings, Zepbound savings, Mounjaro savings and Foundayo cost.

What if your plan doesn't cover your brand?

Keep the card anyway. Novo's Wegovy and Ozempic cards then ring up Novo's self-pay price at your local pharmacy. With Lilly's Mounjaro card, you pay about $500 a month. The Zepbound card gives the same price on the single-dose pen. The Foundayo card starts at about $150.

For Zepbound, Lilly's own self-pay KwikPen usually costs less, from about $300. A late refill at 10 mg or more costs about $700, so refill on time. Compare before you fill.

Can you use an Ozempic or Mounjaro coupon for weight loss?

No. Both cards require a prescription for a use on the drug's FDA label. For Ozempic and Mounjaro, that means type 2 diabetes. Weight loss alone doesn't qualify.

Wegovy, Zepbound and Foundayo are the brands approved for weight loss, and each has its own card. Ask your prescriber which one fits.

Is there a real $0 GLP-1 program?

Yes, for one brand. Novo Nordisk's Patient Assistance Program gives the Ozempic pen free to people with no insurance and a household income at or below 200% of the federal poverty level. That level is the government's yearly income line for poverty.

• Not eligible: anyone with private insurance or Medicaid. People with Medicare drug coverage can no longer get Ozempic through it.
• What it covers: the Ozempic pen.
• How long: enrollment lasts 12 months, and you can reapply.

Wegovy, Zepbound, Mounjaro and Foundayo have no free program. Lilly Cares, Lilly's charity, does list Trulicity, an older weekly shot, for people with type 2 diabetes and no coverage. Ask your doctor whether it fits you.

No insurance: the cheapest real brand-name GLP-1

Both makers sell their drugs at a fixed cash price, called self-pay. You still need a prescription.

• Wegovy or Ozempic pill: about $150 a month to start, rising to about $300 at higher doses. Sold by NovoCare Pharmacy, or at a local pharmacy with the savings card.
• Foundayo pill: about $150 a month to start, from Lilly. The top doses cost about $350, or about $300 if you refill within 45 days.
• Wegovy or Ozempic pen: about $350 a month. Wegovy's 7.2 mg pen costs about $400, and Ozempic 2 mg about $500. New patients pay about $200 for their first two fills at the starting doses, through December 31, 2026.
• Zepbound: about $300 a month at 2.5 mg, about $400 at 5 mg, and about $450 from 7.5 mg if you refill within 45 days. KwikPen at LillyDirect or a local pharmacy, or vials from LillyDirect.
• Mounjaro: about $500 a month at every dose, from LillyDirect.

Prices climb with the dose. Plan your budget on the dose you will stay on, not the starting one. Our GLP-1 without insurance guide compares every cash price.

Medicare: the $50 GLP-1 Bridge

Maker cards are closed to Medicare by federal rules. Since July 1, 2026, Medicare's GLP-1 Bridge gives eligible members Wegovy, Foundayo or the Zepbound KwikPen for $50 a month. It runs through December 31, 2027.

• BMI of 35 or more: you qualify on BMI alone.
• BMI of 30 or more: you also need one of these: a certain type of heart failure, uncontrolled high blood pressure, or moderate kidney disease.
• BMI of 27 or more: you also need one of these: prediabetes, a past heart attack or stroke, or blocked leg arteries that cause symptoms.
• Who is left out: people with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease. Their Part D plan, Medicare's drug coverage, may cover a GLP-1 instead.
• How to start: you need Part D. Your prescriber sends the prescription and confirms you follow a diet and exercise plan. If asked, they also send a prior authorization, meaning approval in advance.

Extra Help, Medicare's low-income drug aid, can't lower the $50. With type 2 diabetes, Part D plans usually cover Ozempic or Mounjaro. In 2026, your yearly out-of-pocket drug costs stop at $2,100.

Does GoodRx work on GLP-1s?

For Wegovy and Ozempic, GoodRx now shows Novo's own self-pay price at retail pharmacies. It won't beat NovoCare, but it shows that price at your usual drugstore.

For Zepbound and Mounjaro, GoodRx barely helps. A coupon lands around $995 to $1,090 a month, close to list price. Lilly's own self-pay price is far lower.

GoodRx may also list Lilly's own self-pay KwikPen price. That is Lilly's offer, not a GoodRx discount. GoodRx replaces your insurance and the savings card. It doesn't add to them.

Compounded GLP-1s: the next step if nothing else fits

Some women fall outside every program above. For them, compounded semaglutide or tirzepatide from a telehealth service is the usual next option. A pharmacy mixes it, and it is not FDA-approved. No maker card applies.

At Eden, semaglutide costs about $100 a month at every dose. Tirzepatide costs about $130. Many other services charge more as the dose goes up. Compare the price at the dose you will stay on, not just the first month.

Are free GLP-1 samples real?

No. Neither Novo Nordisk nor Lilly runs a free sample program for its GLP-1s. Lilly offers a free app and a digital starter kit with tips, but no medicine.

The FDA has sent warning letters to sellers of illegally marketed semaglutide and tirzepatide. It has also found fake compounded products whose labels name pharmacies that don't exist.

• Free or deeply discounted GLP-1s with no prescription and no eligibility check are a scam pattern, not a program.
• Real savings cards and the real assistance program are free to join. A fee to "unlock" a price is a red flag.
• Buy only from a state-licensed pharmacy or a known telehealth service, and ask which pharmacy fills your order.

Why the right program matters more in perimenopause

Many women start a GLP-1 in their 40s or 50s, when weight tends to shift toward the belly. It is often a long-term prescription. List prices run about $1,000 a month or more. The right program can save you thousands of dollars a year.

What each route costs over a year

Pens come in 28-day boxes, so a year means 13 fills. Pills come in 30-day bottles, so 12.

• Savings card, plan covers your brand: about $300 to $325 a year.
• Ozempic assistance program, if you qualify: $0.
• Medicare GLP-1 Bridge: about $600 to $650 a year.
• Wegovy or Ozempic pill, self-pay: about $3,340 a year, stepping up to the usual top dose.
• Zepbound self-pay: about $5,100 to $5,650 for the first year, with on-time refills.
• GoodRx, Zepbound or Mounjaro: about $12,900 to $14,200 a year.
• Compounded semaglutide at Eden: about $1,190 a year, at any dose.

Lilly's self-pay offer ends December 31, 2026. Its KwikPen offer allows at most 11 fills a calendar year. Know which group you're in before you pay: insured and covered, eligible for free Ozempic, on Medicare, or paying cash.